Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Blood Samples From Diverse Adults With Heart and Blood Vessel Disease

Collects blood to build a stem cell bank for people with cardiovascular disease.

Plain-language title generated from the registry record
Registry title: iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease

Key facts

Where
London, CanadaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06371937, who can take part

Where in Canada

  • London Regional Health Science CentreLondon, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Trial code
NCT06371937
Record updated
29 May 2024
Original description
The Investigators will create a clinical database and a Biobank of stem cells derived from the blood of participants with cardiovascular disease. The Investigators will recruit participants from diverse racial and ethnic backgrounds with equal representation from both sexes. The Investigators expect to create stem cells and analyze the blood for protein biomarkers and genetic causes of cardiovascular disease. The stem cell biobank and clinical data will be a powerful tool for studying cardiovascular disease.Read full original descriptionShow less

Blood Biomarkers From Ethnically Diverse Cardiovascular Patients

The Investigators will create a clinical database and a Biobank of stem cells derived from the blood of participants with cardiovascular disease. The Investigators will recruit participants from diverse racial and ethnic backgrounds with equal representation from both sexes. The Investigators expect to create stem cells and analyze the blood for protein biomarkers and genetic causes of cardiovascular disease. The stem cell biobank and clinical data will be a powerful tool for studying cardiovascular disease.

Inclusion: Adult (18 to 80 years of age); Cardiovascular Disease (CVD); Cerebrovascular Disease (CBD); Peripheral Vascular Disease (PVD); Inherited Arrhythmias; Cardiomyopathies; Congenital Heart Disease (CHD); Aortopathy; Hypertension; Cardiometabolic Disease (CMD).

Exclusion: Younger than 18 years of age; Patients not able to provide consent.

ClinicalTrials.gov NCT06371937